Tag Archives: Rising U.S. Cyclospora Cases Underscore Need for Rapid Molecular Testing QIAGEN Says

QIAGEN Showcases PCR and Sequencing Tools for Cyclospora Detection and Public Health Investigations

(IN BRIEF) QIAGEN has highlighted its molecular testing portfolio as U.S. health authorities investigate a growing Cyclospora outbreak. More than 1,600 confirmed cases of cyclosporiasis have been reported in the United States since May 2026, with another 7,000 potential cases … Read the full press release